Gene Delivery Using Physical Methods - Challenges in Delivery of Therapeutic Genomics and Proteomics - page 115

[79] Yoshino H, Hashizume K, Kobayashi E. Naked plasmid DNA transfer to the porcine liver
using rapid injection with large volume. Gene Ther 2006;13:1696-702.
[80] Dagnaes-Hansen F, Holst HU, Sondergaard M, Vorup-Jensen T, Flyvbjerg A, Jensen UB,
et al. Physiological effects of human growth hormone produced after hydrodynamic
gene transfer of a plasmid vector containing the human ubiquitin promotor. J Mol Med
2002;80:665-70.
[81] Hanawa H, Watanabe R, Hayashi M, Yoshida T, Abe S, Komura S, et al. A novel method
to assay proteins in blood plasma after intravenous injection of plasmid DNA. Tohoku J
Exp Med 2004;202:155-61.
[82] Holst HU, Dagnaes-Hansen F, Corydon TJ, Andreasen PH, Jorgensen MM, Kolvraa S,
et al. �D� receptor-GFP fusion proteins: new tools for the characterisation of disease-
causing mutations in the �D� receptor gene. Eur J Hum Genet 2001;9:815-22.
[83] Jiang JJ, Yamato E, Miyazaki J. Intravenous delivery of naked plasmid DNA for in vivo
cytokine expression. Biochem Biophys Res Commun 2001;289:1088-92.
[84] Slattum PS, �oomis AG, Machnik KJ, Watt MA, Duzeski J�, Budker VG, et al.
Efficient in vitro and in vivo expression of covalently modified plasmid DNA. Mol Ther
2003;8:255-63.
[85] Vorup-Jensen T, Jensen UB, �iu H, Kawasaki T, Uemura K, Thiel S, et al. Tail-vein
injection of Mannan-binding lectin DNA leads to high expression levels of multimeric
protein in liver. Mol Ther 2001;3:867-74.
[86] Giladi H, Ketzinel-Gilad M, Rivkin �, Felig Y, Nussbaum O, Galun E. Small interfering
RNA inhibits hepatitis B virus replication in mice. Mol Ther 2003;8:769-76.
[87] Maruyama H, Higuchi N, Nishikawa Y, Kameda S, Iino N, Kazama JJ, et al. High-
level expression of naked DNA delivered to rat liver via tail vein injection. J Gene Med
2002;4:333-41.
[88] Chabicovsky M, Herkner K, Rossmanith W. Overexpression of activin beta (C) or activin
beta (E) in the mouse liver inhibits regenerative deoxyribonucleic acid synthesis of
hepatic cells. Endocrinology 2003;144:3497-504.
[89] Imagawa T, Watanabe S, Katakura S, Boivin GP, Hirsch R. Gene transfer of a fibronectin
peptide inhibits leukocyte recruitment and suppresses inflammation in mouse collagen-
induced arthritis. Arthritis Rheuma 2002;46:1102-8.
[90] �ayzer JM, McCaffrey AP, Tanner AK, Huang Z, Kay MA, Sullenger BA. In vivo activ-
ity of nuclease-resistant siRNAs. RNA 2004;10:766-71.
[91] McCaffrey AP, Hashi K, Meuse �, Shen S�, �ancaster AM, �ukavsky PJ, et al.
Determinants of hepatitis C translational initiation in vitro , in cultured cells and mice.
Mol Ther 2002;5:676-84.
[92] McCaffrey AP, Meuse �, Karimi M, Contag CH, Kay MA. A potent and specific mor-
pholino antisense inhibitor of hepatitis C translation in mice. Hepatology 2003;38:503-8.
[93] Miao CH, Ye X, Thompson AR. High-level factor VIII gene expression in vivo achieved
by non-viral liver-specific gene therapy vectors. Hum Gene Ther 2003;14:1297-305.
[94] Ye PQ, Thompson AR, Sarkar R, Shen ZP, �illicrap DP, Kaufman RJ, et al. Naked DNA
transfer of factor VIII induced transgene specific, species-independent immune response
in hemophilia A mice. Mol Ther 2004;10:117-26.
[95] Eastman SJ, Baskin KM, Hodges B�, Chu QM, Gates A, Dreusicke R, et al.
Development of catheter-based procedures for transducing the isolated rabbit liver with
plasmid DNA. Hum Gene Ther 2002;13:2065-77.
[96] Hagstrom JE, Hegge J, Zhang G, Noble M, Budker V, �ewis D�, et al. A facile non-viral
method for delivering genes and siRNAs to skeletal muscle of mammalian limbs. Mol
Ther 2004;10:386-98.